Drreddy
Current Price
₹ 1,318
Live Data
About Company
Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Ratios
Key fundamental data analysis
Market Cap
₹ 1,10,050 Cr.
Current Price
₹ 1,318
High / Low
₹ 1,380 / 1,148
Stock P/E
26.2
Book Value
₹ 454
Dividend Yield
0.61 %
ROCE
13.6 %
ROE
11.8 %
Face Value
₹ 1.00
Analysis
Cons
- Dividend payout has been low at 13.2% of profits over last 3 years
Quarterly Results
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6315 | 6758 | 6903 | 7237 | 7114 | 7696 | 8038 | 8381 | 8528 | 8572 | 8828 | 8753 | 7546 |
| Expenses | 4781 | 4696 | 4894 | 5214 | 5283 | 5566 | 5962 | 6108 | 6530 | 6398 | 6818 | 6866 | 7164 |
| Operating Profit | 1534 | 2062 | 2008 | 2023 | 1831 | 2130 | 2076 | 2273 | 1998 | 2174 | 2010 | 1888 | 382 |
| OPM % | 24 | 31 | 29 | 28 | 26 | 28 | 26 | 27 | 23 | 25 | 23 | 22 | 5 |
| Other Income | 146 | 178 | 319 | 219 | 201 | 193 | 314 | 154 | 528 | 290 | 330 | 271 | 480 |
| Interest | 35 | 37 | 35 | 39 | 59 | 60 | 76 | 82 | 66 | 83 | 91 | 94 | 106 |
| Depreciation | 316 | 353 | 376 | 374 | 368 | 381 | 397 | 471 | 455 | 476 | 505 | 521 | 557 |
| Profit before tax | 1329 | 1850 | 1917 | 1829 | 1605 | 1883 | 1917 | 1874 | 2005 | 1905 | 1745 | 1543 | 200 |
| Tax % | 28 | 24 | 23 | 24 | 18 | 26 | 30 | 25 | 21 | 26 | 23 | 23 | -11 |
| Net Profit | 960 | 1405 | 1482 | 1381 | 1310 | 1392 | 1342 | 1404 | 1587 | 1410 | 1337 | 1190 | 221 |
| EPS in Rs | 11.53 | 16.87 | 17.77 | 16.56 | 15.7 | 16.69 | 15.05 | 16.94 | 19.09 | 16.99 | 16.14 | 14.5 | 2.65 |
Profit & Loss
| Metrics | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15023 | 15568 | 14196 | 14281 | 15448 | 17517 | 19048 | 21545 | 24670 | 28011 | 32644 | 33700 |
| Expenses | 11515 | 11983 | 11724 | 11930 | 12270 | 15040 | 15173 | 17778 | 18200 | 20078 | 24097 | 27247 |
| Operating Profit | 3508 | 3585 | 2472 | 2351 | 3178 | 2477 | 3874 | 3768 | 6470 | 7933 | 8547 | 6454 |
| OPM % | 23 | 23 | 17 | 16 | 21 | 14 | 20 | 17 | 26 | 28 | 26 | 19 |
| Other Income | 260 | 295 | 172 | 155 | 381 | 670 | 335 | 555 | 971 | 909 | 1119 | 1372 |
| Interest | 108 | 83 | 63 | 79 | 89 | 98 | 97 | 96 | 143 | 171 | 283 | 374 |
| Depreciation | 760 | 939 | 1027 | 1077 | 1135 | 1163 | 1229 | 1165 | 1250 | 1470 | 1704 | 2059 |
| Profit before tax | 2900 | 2859 | 1554 | 1350 | 2336 | 1886 | 2884 | 3061 | 6048 | 7201 | 7680 | 5393 |
| Tax % | 19 | 26 | 19 | 32 | 17 | -7 | 32 | 29 | 25 | 23 | 25 | 23 |
| Net Profit | 2336 | 2131 | 1292 | 947 | 1950 | 2026 | 1952 | 2182 | 4507 | 5578 | 5725 | 4158 |
| EPS in Rs | 27.43 | 24.98 | 15.59 | 11.41 | 23.49 | 24.38 | 23.47 | 26.23 | 54.14 | 66.87 | 67.77 | 50.27 |
| Dividend Payout % | 15 | 16 | 26 | 35 | 17 | 21 | 21 | 23 | 15 | 12 | 12 | 16 |